In my 2020 book Longevity Industry 1.0: Defining the Biggest and Most Complex Industry in Human History, we distilled the complex assembly of deep market intelligence and industry knowledge that Deep Knowledge Group and its Longevity-focused subsidiaries (including Longevity.Capital and Aging Analytics Agency) have developed over the past 8 years into a full-scope understanding of the Global Longevity Industry.

Our work toward defining the Longevity Industry, and our work in creating and publicly disclosing our internally-developed framework for tangible analysis, systematization, and forecasting of the industry in order to optimize our own strategic decision making in this domain, remains as important today as it was when we published the book. Despite the fact that the Longevity Industry has witnessed unprecedented levels of growth and maturation over the past decade, the term Longevity itself, and its fundamental definition, still remains unclear to many people (and to investors in particular), who associate Longevity with such topics as typical anti-aging skin creams and the fitness and wellness industries. 

In reality, Longevity is the deepest of all DeepTech sectors, and occupies the very forefront of advanced biomedicine, sitting at the intersection of many domains of DeepTech and Frontier Technologies. The industry’s intersection with, and reliance upon, advanced technologies does not, however, exclude or preclude the fact that it is also deeply interconnected with specific behavioural and lifestyle interventions. What it does mean, however, is that the scope and sophistication of technology-based tools and methods of optimizing day-to-day Healthy Longevity are large, rapidly increasing, and much broader (and deeper) than many people may realize, extending far beyond simplistic approaches involving diet, exercise and supplements, encompassing DeepTech products and services that are becoming increasingly available to the consumer.

Whereas Longevity Industry 1.0 charted the inception and rise of the industry up to 2020, and provided the methodology and framework for defining and analyzing the industry, its sequel, ‘Longevity Industry 2.0: DeepTech Engineering the Accelerated Trajectory of Human Longevity - The Blueprint and Pathway from Longevity Industry 1.0 to 2.0’, outlines Deep Knowledge Group’s recent work towards formulating the pathway to Longevity Industry 2.0, and presents the framework for safeguarding the sector’s current upward trajectory and ensuring its optimized, sustainable growth towards its next stage and the realization of its practical benefits for humanity by the year 2030. The book outlines several issues (and proposed solutions) that we believe constitute the foremost bottlenecks and risks to a continuing, positive trajectory of development in Longevity science, policy, industry, finance and investment, and present a preliminary preview of the frameworks we are developing to help strategic decision makers, industry participants and the general public take greater control over the actual, real-world development of both the Longevity Industry and Healthy Human Longevity. 

Meanwhile, the next book in the series, ‘Longevity Industry 3.0: Stable Acceleration of Longevity Industrialization to Achieve its Practical Humanitarian Impact by the Year 2027’, will present the framework and toolsets required to maximize the positive societal benefits and neutralize the potentially detrimental consequences of Longevity, and how to accelerate its major practical impacts (including economic growth and stabilization and additional socially-inclusive HALE and QALY-years for humanity ahead of standard timelines - not in 10 years, but in 6.